BTN plans to invest 50 million yuan in the Jinyu Fund, targeting multiple healthcare-related fields
BTN recently announced that it has signed a partnership agreement with Jinyumao Investment Management Co., Ltd., intending to invest 50 million yuan in the Jinyu Fund, becoming one of its limited partners and holding a 5% partnership share. The Jinyu Fund primarily invests in various healthcare-related fields, including consumer healthcare, pharmaceuticals, and medical devices
According to the Zhitong Finance APP, BTN (300957.SZ) announced that the company recently signed the Partnership Agreement of Wuxi Jinyu Maowu Medical Health Industry Investment Partnership (Limited Partnership). The Jinyu Fund is managed by Jinyu Maowu Investment Management Co., Ltd. As one of the limited partners of the Jinyu Fund, the company will use its own funds to subscribe for an investment of 50 million yuan. After this investment is completed, the company will hold a 5% partnership share in the Jinyu Fund.
It is reported that this partnership mainly invests in consumer healthcare and the improvement of national health quality (including health maintenance, medical aesthetics, special medical care, functional foods, etc.), pharmaceuticals (including synthetic biology, innovative drugs, etc.), medical devices, supportive medical industries, AI pharmaceuticals, and other fields
